Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial.

Atar S, Cannon CP, Murphy SA, Rosanio S, Uretsky BF, Birnbaum Y. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial. Am Heart J. 2006 May; 151(5):976.e1-6.

View in: PubMed

subject areas

Acute Disease
Administration, Oral
Aged
Alanine
Anticoagulants
Aspirin
Coronary Disease
Female
Gastrointestinal Hemorrhage
Hospitalization
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Incidence
Male
Middle Aged
Patient Discharge
Platelet Glycoprotein GPIIb-IIIa Complex
Pyrrolidines
Retrospective Studies
Risk Assessment
Severity of Illness Index
Syndrome

authors with profiles

Barry Uretsky